Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Software for Malvern’s NanoSight NTA Systems

Published: Friday, July 18, 2014
Last Updated: Thursday, July 17, 2014
Bookmark and Share
NTA 3.0 from Malvern improves user experience and enhances performance.

Malvern Instruments has launched NTA 3.0, a new version of the software that drives its NanoSight Nanoparticle Tracking Analysis (NTA) systems. With an improved, easy-to-use interface, the new NTA 3.0 software makes accessing programs and protocols quick and convenient.

It also incorporates an upgraded high-resolution particle size distribution algorithm, and supports advanced image analysis, particle detection and tracking, as well as providing improved vibration correction.

The new software is designed for use across the complete NanoSight NTA range and will be integral to all new systems shipped, while existing users can download their free upgrade via the appropriate product page on the Malvern website:

• NanoSight NS300 www.malvern.com/ns300sw
• NanoSight LM10 www.malvern.com/lm10sw
• NanoSight NS500 www.malvern.com/ns500sw

Malvern NanoSight systems use Nanoparticle Tracking Analysis (NTA) to characterize nanoparticles in solution in the size range 10 nm to 2000 nm (depending on the sample). Each particle is analyzed individually by direct observation and measurement of diffusion events.

This particle-by-particle methodology produces high resolution results for particle size distribution and concentration, while visual validation provides additional data confidence. Both particle size and concentration are measured, while a fluorescence mode provides differentiation of labeled or naturally fluorescing particles.

NTA 3.0 features automatic, integrated hardware detection and communication for all the systems in the NanoSight range. Compared with previous versions it generates fewer files per experiment and results are displayed on clear, concise spreadsheets. Particle size distributions are shown as histograms for easy interpretation.

NanoSight NTA systems are part of Malvern’s expanding portfolio for characterization at the nanoscale. By updating software for greater ease of use and more efficient testing, NanoSight NTA users can be sure of getting the best possible performance from their system. Visit the Malvern website for details or to download:

• NanoSight NS300 www.malvern.com/ns300sw
• NanoSight LM10 www.malvern.com/lm10sw
• NanoSight NS500 www.malvern.com/ns500sw


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Malvern Completes Acquisition of MicroCal
Company announces purchase of Archimedes product from Affinity Biosensors.
Friday, July 25, 2014
Malvern to Acquire MicroCal Business from GE
Malvern Instruments has entered into an agreement with GE Healthcare Life Sciences to acquire the company’s MicroCal™ microcalorimetry business.
Wednesday, June 04, 2014
Regional Growth Fund Success Sees Malvern Instruments Stepping up UK Recruitment
£3 million support from the UK Government’s Regional Growth Fund (RGF) will lead to the creation of 47 new jobs in the UK over the next five years.
Tuesday, May 20, 2014
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
Testing Nanoparticle Drug Delivery in Dogs
Scientists have tested a nanoparticle drug delivery against bone cancer in dogs with promising results.
Targeting Autoimmunity
Researchers have developed a strategy to treat a rare autoimmune disease which could lead to treatments of other autoimmune diseases.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Development in Preventing Macular Degeneration
Following macular degeneration insight, promising drugs to prevent vision loss have been identified.
Improving Tumour Therapy with Nanoparticles
UHN nanoparticle called PEARLs is a promising utilisation of photo-thermal therapy for cancer treatment.
New Antidepressant Treatment Discovered
Scientists have demonstrated how gene therapy could lead to new treatments for depression.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!